Literature DB >> 4066151

Synthesis of thymosin alpha 1 by fragment condensation using tert.-butyl side chain protection.

A M Felix, E P Heimer, C T Wang, T J Lambros, J Swistok, M Roszkowski, M Ahmad, D Confalone, J W Scott, D Parker.   

Abstract

A novel synthesis of thymosin alpha 1 by classical methods using seven tert.-butyl side chain protected fragments is described. Optimum conditions were found for the final DCC/HOBt coupling of the two key intermediates; decapeptide and octadecapeptide. Thymosin alpha 1 was purified by two stages of preparative HPLC (partial purification with C8 and final purification with C18 reverse phase silica gel) to give a 30% overall yield for the final four stages of synthesis (including catalytic hydrogenation of octadecapeptide, coupling, deprotection and purification). The product was shown to be homogeneous by thin-layer and paper high voltage electrophoresis, isoelectric focusing analysis, thin-layer chromatography and high performance liquid chromatography. Amino acid analysis, optical rotation, 1H-n.m.r. spectroscopy, FAB mass spectroscopy and peptide mapping after tryptic digestion confirmed the structure of thymosin alpha 1. Three minor stereoisomer contaminants were isolated by HPLC and characterized as [D-Lys14]-thymosin alpha 1, [D-Lys17]-thymosin alpha 1 and [D-Ala3]-thymosin alpha 1 resulting from racemization at Lys14, Lys17 and Ala3 during the coupling of the fragments. A final contaminant, isolated by HPLC, was characterized as N alpha-isobutyloxycarbonyl-thymosin alpha 1 (15-28), which results from "wrong way opening" of an activated mixed anhydride.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4066151     DOI: 10.1111/j.1399-3011.1985.tb03190.x

Source DB:  PubMed          Journal:  Int J Pept Protein Res        ISSN: 0367-8377


  1 in total

1.  Prothymosin alpha expression is associated to cell division in rat testis.

Authors:  E Rosón; R Gallego; T García-Caballero; E P Heimer; A M Felix; F Domínguez
Journal:  Histochemistry       Date:  1990
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.